Depletion of host cell components from live vector vaccines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 1, 2016
Grant Date -
Oct 17, 2013
app pub date -
Nov 23, 2011
filing date -
Nov 26, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
It is desirable to produce live vaccines, which are highly attenuated and which do only contain minimal or no animal-derived components. The production of highly attenuated live viruses can be better achieved when using specifically designed cell lines as producer substrate as opposed to using less defined primary cells. However, live viruses, thus produced comprise undesirable components from the cell lines and cell culture. The present invention relates to methods of production and purification of live enveloped viruses, which are suitable for vaccination.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully